Intravenous immunoglobulin in the treatment of snake bite envenoming: a pilot study.
Ceylon Med J
;
1994 Dec; 39(4): 173-5
Artigo
em Inglês
| IMSEAR
| ID: sea-47785
ABSTRACT
The standard treatment for snake bite envenoming is with snake antivenon (AVS). Reports to date on the efficacy of AVS have been equivocal. Some studies have shown a beneficial effect on the coagulopathy, while its effect on neurotoxicity is questionable. AVS therapy is also associated with a high incidence of reactions. We conducted a pilot study to compare the standard AVS therapy, with AVS plus intravenous immunoglobulin (IVIG), in the treatment of snake bite evenoming. Our study indicates that the addition of IVIG to the standard AVS regimen, eliminates the need to repeat AVS for envenoming associated with coagulopathy.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Mordeduras de Serpentes
/
Humanos
/
Antivenenos
/
Projetos Piloto
/
Resultado do Tratamento
/
Imunoglobulinas Intravenosas
Tipo de estudo:
Ensaio Clínico Controlado
Idioma:
Inglês
Revista:
Ceylon Med J
Ano de publicação:
1994
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS